Drug Search Results
More Filters [+]

SST-6007

Alternative Names: sst-6007, sst6007, sst 6007
Latest Update: 2017-10-03
Latest Update Note: Clinical Trial Update

Product Description

SST-6007, developed with SSTs proprietary KNOSISTM technology, is a patented topical cream product containing 5% sildenafil citrate by weight.

Mechanisms of Action: PDE5 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Strategic Science & Technologies
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for SST-6007

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Sexual Dysfunction, Physiological

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

SST-6007-02-01

P2

Completed

Sexual Dysfunction, Physiological

2017-05-01

Recent News Events

Date

Type

Title